RheeGen, a trailblazer in regenerative medicine, has introduced a groundbreaking advancement in regenerative therapy with the launch of RheeGen, the first-of-its-kind transdermal topical cream containing bioactive biomolecules derived from human mesenchymal stem cells (MCS).
RheeGen was established to allow the general population easier access to the powerful healing properties of regenerative medicine.
“RheeGen represents a significant leap forward in regenerative medicine,” said Tommy Rhee, DC, RheeGen’s CEO and founder. “Our commitment to innovation and accessibility has led to the development of a transdermal regenerative cream that redefines the possibilities of at-home regenerative therapy.”
This new topical features:
- Bioactive biomolecules: RheeGen contains an FDA-compliant bioactive biomolecule formula derived from human mesenchymal stem cells (MSC) sourced from the Wharton’s jelly of the umbilical cord, currently only found in stem cell injections. The bioactive biomolecules are encased in lipid nanoparticles and lyophilized to offer up to 12 months of stabilization at refrigerated temperatures.
- Low risk and simple application: RheeGen’s topical cream has a low risk of infection due to its noninvasive nature. Easy self-application eliminates the hassle of scheduling and hiring medical doctors or nurse practitioners to perform injections.
- Penetrating power: RheeGen’s patent-pending formula goes beyond the three layers of the skin, ensuring that human MSC-derived components effectively reach target areas.
Unlike other products on the market that rely on plant-based stem cells, RheeGen harnesses the power of human MSCs, offering a more advanced and effective solution. It is also the first of its kind to breach the protective layers of the skin, ensuring that the bioactive biomolecule components reach the targeted area for enhanced effectiveness. Affordable and user-friendly, it requires no doctors or medical facilities to administer. It is a noninvasive option that is up to 95% more cost-effective than other regenerative treatments, making it a user-friendly solution for at-home use.
The RheeGen Bioactive Biomolecules Kit, designed to elevate performance and recovery, features RheeGen Alpha and RheeGen Omega. Used together, these components synergize to deliver outstanding results.
For more information, visit rheegen.com.
About RheeGen
RheeGen is a Tampa-based company specializing in cutting-edge solutions for regenerative medicine. With a focus on innovation and accessibility, RheeGen is committed to advancing the field of regenerative therapy for the benefit of individuals worldwide. RheeGen was founded by esteemed sports physiotherapist and Tampa Bay chiropractor Dr. Tommy Rhee. Dr. Rhee saw a need within the professional sports world for a noninvasive regenerative medicine treatment that could be used by athletes while continuing physical activity. RheeGen was born out of the necessity for more readily available regenerative medicine treatments and is now positioned as an economical, low-risk and noninvasive solution for practitioners looking to introduce regenerative medicine into their practices.
Disclaimer
This press release contains forward-looking statements that are subject to various risks and uncertainties. Actual results may differ materially from expectations. RheeGen undertakes no obligation to update any forward-looking statements.
